Profile data is unavailable for this security.
About the company
Double Bond Pharmaceutical International AB is a manufacturer of pharmaceutical preparation. The company is located in Uppsala, Sweden. It develops medicinal products for patients suffering from diseases such as cancer, inflammation, asthma or diabetes
- Revenue in SEK (TTM)1.49m
- Net income in SEK-16.07m
- Incorporated2014
- Employees10.00
- LocationDouble Bond Pharmaceutical International AB (publ)Virdings Alle 32 BUPPSALA 75450SwedenSWE
- Websitehttps://www.doublebp.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ATTANA AB | 5.52m | -11.54m | 28.71m | 10.00 | -- | 1.66 | -- | 5.20 | -0.0367 | -0.0367 | 0.0168 | 0.0447 | 0.1945 | -0.4851 | 2.16 | 552,453.00 | -40.62 | -37.18 | -52.55 | -46.66 | 129.03 | 175.97 | -208.89 | -254.69 | 0.3496 | -5.53 | 0.1539 | -- | -32.89 | 6.61 | 5.80 | -- | 8.21 | -- |
Gabather AB | 0.00 | -10.59m | 29.18m | -- | -- | -- | -- | -- | -0.6814 | -0.6814 | 0.00 | -0.1489 | 0.00 | -- | -- | -- | -144.39 | -56.57 | -1,110.23 | -67.36 | -- | -- | -- | -17,298,800.00 | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- |
Fluicell AB | 1.86m | -29.02m | 40.33m | 12.00 | -- | 1.60 | -- | 21.65 | -0.1936 | -0.1936 | 0.0109 | 0.0527 | 0.0796 | 0.5404 | 1.74 | 109,588.20 | -123.93 | -87.55 | -164.04 | -126.02 | 20.93 | 72.97 | -1,557.49 | -650.23 | 3.02 | -- | 0.00 | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
SoftOx Solutions AS | 4.25m | -75.88m | 42.86m | 7.00 | -- | -- | -- | 10.08 | -1.71 | -1.71 | 0.0152 | -0.0179 | 0.0442 | -- | 1.16 | 612,427.10 | -78.78 | -50.11 | -146.86 | -63.61 | -- | -- | -1,784.14 | -639.34 | 0.0615 | -6.83 | 1.92 | -- | -1.88 | 10.06 | 44.55 | -- | 39.43 | -- |
Double Bond Phrmcutcl Intrntnl AB (publ) | 1.49m | -16.07m | 44.78m | 10.00 | -- | 6.61 | -- | 30.04 | -0.1635 | -0.1635 | 0.0145 | 0.0638 | 0.1306 | -- | 26.83 | 149,078.00 | -140.73 | -80.90 | -200.07 | -106.45 | -389.14 | -1,073.66 | -1,078.00 | -1,360.03 | -- | -2.71 | 0.00 | -- | 10.25 | 135.07 | -14.36 | -- | -- | -- |
Modus Therapeutics Holding AB | 0.00 | -14.96m | 45.82m | 2.00 | -- | 3.14 | -- | -- | -0.7495 | -0.7495 | 0.00 | 0.4056 | 0.00 | -- | -- | 0.00 | -128.10 | -141.06 | -502.76 | -278.44 | -- | -- | -- | -- | -- | -11.79 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
Klaria Pharma Holding AB (publ) | -6.53m | -20.10m | 49.44m | 5.00 | -- | 1.39 | -- | -- | -0.1847 | -0.4021 | -0.0621 | 0.2743 | -0.0794 | -- | -- | -1,305,600.00 | -24.44 | -37.28 | -40.23 | -51.56 | -- | -- | -- | -2,077.34 | -- | -1.87 | 0.00 | -- | -100.00 | -- | 71.17 | -- | -- | -- |
Orphazyme A/S | 0.00 | -39.68m | 50.56m | 1.00 | -- | 2.33 | -- | -- | -737.75 | -737.75 | 0.00 | 403.34 | 0.00 | -- | -- | 0.00 | -68.42 | -76.08 | -94.18 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
Combigene AB | 3.70m | -35.24m | 61.38m | 8.00 | -- | 0.6003 | -- | 16.58 | -1.78 | -1.78 | 0.187 | 5.16 | 0.0294 | -- | 1.27 | 462,765.00 | -27.99 | -13.00 | -29.40 | -14.58 | -- | -- | -951.98 | -58.77 | -- | -- | 0.00 | -- | -79.23 | 268.58 | -479.27 | -- | -24.02 | -- |
Nidhogg Resources Holding AB (publ) | 32.00k | -13.93m | 61.65m | 3.00 | -- | -- | -- | 1,926.58 | -0.1267 | -0.1267 | 0.0003 | -0.0014 | 0.0072 | -- | 0.0134 | -- | -311.00 | -83.17 | -462.65 | -97.89 | -29,487.50 | -- | -43,525.00 | -- | -- | -818.29 | -- | -- | -- | -- | 8.95 | -- | -- | -- |
PCI Biotech Holding ASA | 2.97m | -20.15m | 66.66m | 7.00 | -- | 1.72 | -- | 22.47 | -0.5443 | -0.5443 | 0.0801 | 1.05 | 0.0556 | -- | 0.6848 | 427,142.80 | -37.78 | -36.44 | -41.97 | -40.14 | -- | -- | -679.43 | -1,055.43 | -- | -- | 0.0081 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
Data as of Jul 05 2024. Currency figures normalised to Double Bond Pharmaceutical International AB (publ)'s reporting currency: Swedish Krona SEK